Skip to content

Engineering Solution & Consultancy

Qualification comes before the registration batches

  • Engineering Solution & Consultancy
  • 1 min read

Registration batches made before the equipment was qualified leave the dossier resting on stability data that is hard to defend.

The order that avoids it is set at design stage:

  1. Fix the products and the target markets in the design basis, because the evidence the facility has to produce differs between EU, WHO and US markets.
  2. Qualify the facility, utilities and equipment.
  3. Make the registration batches on the qualified equipment.
  4. Put them on stability, then compile and submit the dossier.
  5. Validate the process and host the inspection. Whether each of these comes before or after the submission depends on the target region and on the process.

EU GMP Annex 15 (2015) says equipment, facilities, utilities and systems used for process validation should be qualified. The ICH stability guideline, Q1A(R2), says the manufacturing process for the primary batches should simulate the one to be applied to production batches and give product of the same quality.

Neither text says "qualified" for the registration batches. That link is our reading: a batch can represent the commercial process only on equipment whose performance has been shown.

On the project schedule, then, the dossier waits for PQ, a later milestone than mechanical completion. The stability study starts when those batches are made, so a delay in qualification moves the earliest submission date with it.

Related

More on this subject

The receiving site validates the process again

A process validated at the sending site was validated with that site's equipment, utilities and people. WHO's technology transfer guideline defines validation batches as those produced by the receiving unit, and EU GMP Annex 15 (2015) covers site transfers. The earlier validation supports the new protocol. With bracketing, the number of batches could be reduced; the content of the previous validation should be available.

InsightRead

CPV: one abbreviation, two different things

Continued process verification is the FDA's Stage 3: assurance during routine production that the process remains in a state of control. EU GMP Annex 15 (2015) calls it ongoing process verification. Continuous process verification, defined in ICH Q8(R2), is an alternative approach to validation. Write the phrase out and cite its source.

InsightRead